HomeTOP STORIESProthena hits 52-week low amid downgrades after late-stage trial setback Prothena hits 52-week low amid downgrades after late-stage trial setback By rogerjudd May 27, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleHSBC sacks more than two dozen analysts in research department shakeup – reportNext articleEuropean markets uptick amid eased concerns of trade conflict with the US latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
